1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2024

• 1.1 Ensure treatment decisions are timely, rely on evidence-based guidelines, capture key elements within the social determinants of health, and are made collaboratively with people with diabetes and care partners based on individual preferences, prognoses, comorbidities, and informed financial considerations. B

• 1.2 Align approaches to diabetes management with the Chronic Care Model. This model emphasizes person-centered team care, integrated long-term treatment approaches to diabetes and comorbidities, and ongoing collaborative communication and goal setting between all team members. A

• 1.3 Care systems should facilitate in-person and virtual team-based care, include those knowledgeable and experienced in diabetes management as part of the team, and utilize patient registries, decision support tools, and community involvement to meet needs of individuals with diabetes. B

• 1.4 Assess diabetes health care maintenance (Table 4.1) using reliable and relevant data metrics to improve processes of care and health outcomes, with attention to care costs, individual preferences and goals for care, and treatment burden. B

Population health is defined as “the health outcomes of a group of individuals, including the distribution of health outcomes within the group”; these outcomes can be measured in terms of health outcomes (mortality, morbidity, and functional status), disease burden (incidence and prevalence), and behavioral and metabolic factors (physical activity, nutrition, A1C, etc.) (1). Clinical practice recommendations for health care professionals are tools that can ultimately improve health across populations; however, for optimal outcomes, diabetes care must also be individualized for each person with diabetes and across their life span. Thus, efforts to improve population health will require a combination of policy-level, system-level, and person-level approaches. With such an integrated approach in mind, the American Diabetes Association (ADA) highlights the importance of person-centered care, defined as care that considers an individual’s comorbidities and prognoses; is respectful of and responsive to individual preferences, needs, and values; and ensures that the individual’s values guide all clinical decisions (2). Furthermore, wider social determinants of health (SDOH)—often out of direct control of the individual and potentially representing lifelong risk—contribute to health care and psychosocial outcomes and must be addressed to improve all health outcomes (3). Clinical practice recommendations, whether based on evidence or expert opinion, are intended to guide an overall approach to care. The science and art of health care come together when the clinician makes treatment decisions for a person who may not meet the eligibility criteria used in the studies on which guidelines are based. Recognizing that one size does not fit all, the standards presented here provide guidance for when and how to adapt recommendations for an individual. This section provides guidance for health care professionals as well as health systems, payers, and policymakers.

The proportion of people with diabetes who achieve recommended A1C, blood pressure, and LDL cholesterol levels has fluctuated over the years, with some improvement over time (4). Glycemic management and management of cholesterol through dietary intake remain challenging. In 2015–2018, just 50.5% of U.S. community-dwelling adults with diabetes achieved A1C <7% and 75.4% achieved A1C <8%. The goal blood pressure of <130/80 mmHg was achieved by just 47.7% adults with diabetes, while 70.4% achieved blood pressure <140/90 mmHg. Lipid control, then defined as non-HDL cholesterol <130 mg/dL, was achieved by 55.7% adults with diabetes, and all three risk factors were controlled by just 22.2%. Importantly, many people who did not attain A1C, blood pressure, and lipid goals are not receiving any or adequate pharmacotherapy for glycemic, hypertension, and dyslipidemia management, respectively, which underscores the vital and urgent need for care delivery systems to engage and support people living with diabetes. Certain segments of the population, such as young adults and individuals with complex comorbidities, financial or other social hardships, and/or limited English proficiency, as well as individuals in ethnic minority populations, face particular challenges to goal-based care (5–7). A U.S. population–based study based on the National Health and Nutrition Examination Survey (NHANES) showed that younger people with diabetes, individuals who are Mexican American or non-Hispanic Black, those with lower level of educational attainment, and those who are underinsured are most likely to be undertreated, particularly for glycemic control (4). The persistent variability in the quality of diabetes care across health care professionals and practice settings indicates that substantial system-level improvements are still needed.

Diabetes and its associated health complications pose a significant financial burden to individuals and society. It is estimated that the annual cost of diagnosed diabetes in the U.S. in 2022 was $413 billion, including $307 billion in direct health care costs and $106 billion in reduced productivity. After adjusting for inflation, the economic costs of diabetes increased by 7% between 2017 and 2022 and by 35% from 2012 to 2022 (8). This is attributed to the increased prevalence of diabetes and the increased cost per person with diabetes. People living with diabetes also face financial hardship, which is correlated with higher A1C, diabetes distress, and depressive symptoms (9). Therefore, ongoing population health strategies like the Chronic Care Model (CCM) are needed to reduce costs to the health care system and to people with diabetes and to provide optimized care.

Numerous interventions to promote the recommended standards have been implemented. However, a major barrier to optimal care is a delivery system that is often fragmented, lacks clinical information capabilities, duplicates services, and is poorly designed for the coordinated delivery of chronic care. The CCM is a commonly used framework for describing diabetes care programs (10).

The CCM includes six core elements to optimize the care of people with chronic disease:

1. Delivery system design (moving from a reactive to a proactive care delivery system where planned visits are coordinated through a team-based approach)

2. Self-management support

3. Decision support, particularly at the point of care during a clinical encounter (basing care on evidence-based, effective care guidelines)

4. Clinical information systems (using registries that can provide person-specific and population-based support to the care team)

5. Community resources and policies (identifying or developing resources to support healthy lifestyles)

6. Health systems (to create a quality-oriented culture)

A 5-year effectiveness study of the CCM in 53,436 people with type 2 diabetes in the primary care setting suggested that the use of this model of care delivery reduced the cumulative incidence of diabetes-related complications and all-cause mortality (11). Individuals who were enrolled in the CCM experienced a reduction in cardiovascular disease risk by 56.6%, microvascular complications by 11.9%, and mortality by 66.1% (11). In addition, another study suggested that health care utilization was lower in the CCM group, which resulted in health care savings of $7,294 per individual over the study period (12).

Redefining the roles of the health care delivery team and empowering self-management of people with diabetes are fundamental to the successful implementation of the CCM (13). Collaborative, interprofessional teams are best suited to provide care for people with chronic conditions such as diabetes and to facilitate individuals’ self-management (14–16). There are references to guide the implementation of the CCM into diabetes care delivery, including opportunities and challenges (17).

Optimal diabetes management requires an organized, systematic approach and the involvement of a coordinated team of dedicated health care professionals working in an environment where person-centered, high-quality care is a priority (7,17–19). While many diabetes care processes have improved nationally in the past decade, the overall quality of care for people with diabetes remains suboptimal (4). Efforts to increase the quality of diabetes care include providing care that is concordant with evidence-based guidelines (20); expanding the role of teams to implement more intensive disease management strategies (7,16,21,22); tracking medication-taking behavior at a systems level (23); redesigning the organization of the care process (24); implementing electronic health record (EHR) tools (25,26); empowering and educating people with diabetes (27,28); removing financial barriers and reducing patient out-of-pocket costs for diabetes education, eye exams, diabetes technology, and essential medications (7,29); leveraging telehealth capabilities to improve access to care (30); assessing and addressing psychosocial issues (31,32); and identifying, developing, and engaging community resources and public policies that support healthy lifestyles (33). The National Diabetes Education Program maintains an online resource (cdc.gov/diabetes/professional-info/training.html) to help health care professionals design and implement more effective health care delivery systems for those with diabetes. Given the pluralistic needs of people with diabetes and that the constant challenges they experience vary over the course of disease management (complex insulin treatment plans, new technology, etc.), a diverse team with complementary expertise is consistently recommended (34).

The care team, which centers around the person with diabetes, should avoid therapeutic inertia and prioritize timely and appropriate intensification of behavior change (nutrition and physical activity) and/or pharmacologic therapy for individuals who have not achieved the recommended metabolic goals (35–37). Strategies shown to improve care team behavior and thereby catalyze reductions in A1C, blood pressure, and/or LDL cholesterol include engaging in explicit and collaborative goal setting with people with diabetes (38,39); integrating evidence-based guidelines and clinical information tools into the process of care (20,40,41); identifying and addressing language, numeracy, or cultural barriers to care (41–43); soliciting performance feedback, setting reminders, and providing structured care (e.g., guidelines, formal case management, and patient education resources) (7); and incorporating care management teams including nurses, dietitians, pharmacists, and other health care professionals (21,42). In addition, initiatives such as the Patient-Centered Medical Home can improve health outcomes by fostering comprehensive primary care and offering new opportunities for team-based chronic disease management (43,44).

Telehealth is a growing field that may increase access to care for people with diabetes. The American Telemedicine Association defines telemedicine as the use of medical information exchanged from one site to another via electronic communications to improve a patient’s clinical health status. Telehealth includes a growing variety of applications and services using two-way video, smartphones, wireless tools, and other forms of telecommunications technology (45). Often used interchangeably with telemedicine, telehealth describes a broader range of digital health services in health care delivery (46). This includes synchronous, asynchronous, and remote patient monitoring.

Telehealth should be used complementary to in-person visits to optimize glycemic management in people with unmanaged diabetes (47). Increasingly, evidence suggests that various telehealth modalities may facilitate reducing A1C in people with type 2 diabetes compared with usual care or in addition to usual care (48), and findings suggest that telemedicine is a safe method of delivering care for people with type 1 diabetes in rural areas (49). For rural populations or those with limited physical access to health care, telemedicine has a growing body of evidence for its effectiveness, particularly with regard to glycemic management as measured by A1C (30,50–52). In addition, evidence supports the effectiveness of telehealth in diabetes, hypertension, and dyslipidemia interventions (53) as well as the telehealth delivery of motivational interviewing (54). Interactive strategies that facilitate communication between health care professionals and people with diabetes, including the use of web-based portals or text messaging and those that incorporate medication adjustment, appear more effective. Telehealth and other virtual environments can also be used to offer diabetes self-management education and clinical support and remove geographic and transportation barriers for individuals living in under-resourced areas or with disabilities (55). Telehealth resources can also have a role in addressing the SDOH in young adults with diabetes (56). However, limited data are available on the effectiveness across different populations (57).

Successful diabetes care also requires a systematic approach to supporting the behavior-change efforts of people with diabetes. High-quality diabetes self-management education and support (DSMES) has been shown to improve patient self-management, satisfaction, and glucose outcomes. National DSMES standards call for an integrated approach that includes clinical content and skills, behavioral strategies (goal setting, problem-solving), and engagement with psychosocial concerns. Increasingly, such support is being adapted for online platforms that have the potential to promote patient access to this important resource. These curriculums need to be tailored to the needs of the intended populations, including addressing the “digital divide,” i.e., access to the technology required for implementation (58–61).

For more information on DSMES, see Section 5, “Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes.”

The cost of diabetes medications and devices is an ongoing barrier to achieving glycemic goals. Up to 25% of people with diabetes who are prescribed insulin report cost-related insulin underuse (62). Insulin underuse due to cost has also been termed “cost-related medication non-adherence” (here referred to as cost-related barriers to medication use). There are recommendations from the ADA Insulin Access and Affordability Working Group for approaches to this issue from a systems level (63). Recommendations including concepts such as cost-sharing for insured people with diabetes should be based on the lowest price available, the list price for insulins that closely reflects the net price, and health plans that ensure people with diabetes can access insulin without undue administrative burden or excessive cost (63). In 2023, three major insulin manufacturers lowered the prices of insulin, which may help reduce the financial burden of diabetes management, although costs for insulin delivery and glucose monitoring remain high. People with diabetes should be screened for financial burden of treatment, cost-related barriers to medication use, and rationing of other essential services due to medical costs (64).

The cost of medications (not only insulin) influences prescribing patterns and medication use because of burden on the person with diabetes and lack of secondary payer support (public and private insurance) for effective approved glucose-lowering, cardiovascular disease risk-reducing, and weight management therapeutics. Financial barriers remain a major source of health disparities, and costs should be a focus of treatment goals (65). (See tailoring treatment for social context and treatment considerations.) Reduction in cost-related barriers to medication use is associated with better biologic and psychologic outcomes, including quality of life (66).

The Affordable Care Act and Medicaid expansion have increased access to care for many individuals with diabetes, emphasizing the protection of people with preexisting conditions, health promotion, and disease prevention (67). In fact, health insurance coverage increased from 84.7% in 2009 to 90.1% in 2016 for adults with diabetes aged 18–64 years. As of early 2022, more than 35 million people in the U.S. were enrolled in some form of Affordable Care Act–related health insurance (68). Coverage for those aged ≥65 years remained nearly universal (69). People with diabetes who have either private or public insurance coverage are more likely to meet quality indicators for diabetes care (70). As mandated by the Affordable Care Act, the Agency for Healthcare Research and Quality developed a National Quality Strategy based on triple aims that include improving the health of a population, overall quality and patient experience of care, and per capita cost (71,72). As health care systems and practices adapt to the changing landscape of health care, it will be important to integrate traditional disease-specific metrics with measures of patient experience, as well as cost, in assessing the quality of diabetes care (73,74). Information and guidance specific to quality improvement and practice transformation for diabetes care are available from the National Institute of Diabetes and Digestive and Kidney Diseases guidance on diabetes care and quality (75) Using patient registries and EHRs, health systems can evaluate the quality of diabetes care being delivered and perform intervention cycles as part of quality improvement strategies (76). Improvement of health literacy and numeracy is also a necessary component to improve care (77,78). Critical to these efforts is health professional adherence to clinical practice recommendations (Table 4.1) and the use of accurate, reliable data metrics that include sociodemographic variables to examine health equity within and across populations (79).

In addition to quality improvement efforts, other strategies that simultaneously improve the quality of care and potentially reduce costs are gaining momentum and include reimbursement structures that, in contrast to visit-based billing, reward the provision of appropriate and high-quality care to achieve metabolic goals (80), value-based payments, and incentives that accommodate personalized care goals (7,81). (Also see cost considerations for medication-taking behaviors, above, regarding cost-related barriers to medication use.)

• 1.5 Assess food insecurity, housing insecurity/homelessness, financial barriers, and social capital/social community support to inform treatment decisions, with referral to appropriate local community resources. A

• 1.6 Provide people with diabetes with additional self-management support from lay health coaches, navigators, or community health workers when available. A

• 1.7 Consider the involvement of community health workers to support the management of diabetes and cardiovascular risk factors, especially in underserved communities and health care systems. B

Health inequities related to diabetes and its complications are well documented, are heavily influenced by SDOH, and have been associated with greater risk for diabetes, higher population prevalence, and poorer diabetes outcomes (82–86). SDOH are defined as the economic, environmental, political, and social conditions in which people live and are responsible for a major part of health inequality worldwide (87). Greater exposure to adverse SDOH over the life course results in poor health (88). The ADA recognizes the association between social and environmental factors and the prevention and treatment of diabetes and has issued a call for research that seeks to better understand how social determinants influence behaviors and how the relationships between these variables might be modified for the prevention and management of diabetes (89,90). While a comprehensive strategy to reduce diabetes-related health inequities in populations has not been formally studied, general recommendations from other chronic disease management and prevention models can be drawn upon to inform systems-level strategies in diabetes (91). For example, the National Academy of Medicine has published a framework for educating health care professionals on the importance of SDOH (92). Furthermore, there are resources available for the inclusion of standardized sociodemographic variables in EHRs to facilitate the measurement of health inequities and the impact of interventions designed to reduce those inequities (74,92,93).

SDOH are not consistently recognized and often go undiscussed in the clinical encounter (85). Among people with chronic illnesses, two-thirds of those who reported not taking medications as prescribed due to cost-related barriers to medication use never shared this with their physician (94). A study using data from the National Health Interview Survey (NHIS) (85) found that one-half of adults with diabetes reported financial stress and one-fifth reported food insecurity. A Canadian study noted an association of one or more adverse SDOH and health care utilization and poor diabetes outcomes in high-risk children with type 1 diabetes (94). It is therefore important for people with diabetes to be screened for SDOH during clinical encounters and be referred to appropriate clinical and community resources to address these needs. Health systems may benefit from compiling an inventory of such resources to facilitate referrals at the point of care. Policies and payment models that support addressing SDOH, both within and outside the health care setting, are needed to ensure that these efforts are both feasible and sustainable. One example of a state-wide payment model that incentivizes value-based care, addressing SDOH andfunding community-based health care professionals, is the Maryland Total Cost of Care Model, although it is currently limited by a narrow focus such as preventing diabetes rather than overall diabetes care quality (95,96).

Another population in which such issues must be considered is older adults, for whom social difficulties may impair quality of life and increase the risk of functional dependency (97) (see Section 13, “Older Adults,” for a detailed discussion of social considerations in older adults). Creating systems-level mechanisms to screen for SDOH may help overcome structural barriers and communication gaps between people with diabetes and health care professionals (85,98). Pilot studies have proven the effectiveness of identifying SDOH by using validated screening tools (99). In addition, brief, validated screening tools for some SDOH exist and could facilitate discussion around factors that significantly impact treatment during the clinical encounter. Below is a discussion of assessment and treatment considerations in the context of food insecurity, homelessness, limited English proficiency, limited health literacy, and low literacy.

Food insecurity is the unreliable availability of nutritious food and the inability to consistently obtain food without resorting to socially unacceptable practices. Over 18% of the U.S. population reported food insecurity between 2005 and 2014 (100). The rate is higher in some racial and ethnic minority groups, including African American and Latino populations, low-income households, and homes headed by single mothers. The food insecurity rate in individuals with diabetes may be up to 20% (101). Additionally, the risk for type 2 diabetes is increased twofold in those with food insecurity (89) and has been associated with lower engagement in self-care behaviors and medication use, depression, diabetes distress, and worse glycemic management when compared with individuals who are food secure (102–104). Older adults with food insecurity are more likely to have emergency department visits and hospitalizations compared with older adults who do not report food insecurity (105). Risk for food insecurity can be assessed with a validated two-item screening tool (106) that includes the following statements: 1) “Within the past 12 months, we worried whether our food would run out before we got money to buy more” and 2) “Within the past 12 months the food we bought just didn’t last, and we didn’t have money to get more.” An affirmative response to either statement had a sensitivity of 97% and specificity of 83%. Interventions such as food prescription programs are considered promising to address food insecurity by integrating community resources into primary care settings and directly dealing with food deserts in underserved communities (107,108).

In those with diabetes and food insecurity, the priority is mitigating the increased risk for uncontrolled hyperglycemia and severe hypoglycemia. The reasons for the increased risk of hyperglycemia include the steady consumption of inexpensive carbohydrate-rich processed foods, binge eating, financial constraints to filling diabetes medication prescriptions, and anxiety and depression leading to poor diabetes self-care behaviors. Hypoglycemia can occur due to inadequate or erratic carbohydrate consumption following the administration of sulfonylureas or insulin. See Tables 9.2–9.4 for drug-specific and patient factors, including cost and risk of hypoglycemia, which may be important considerations for adults with food insecurity and type 2 diabetes. Health care professionals should consider these factors when making treatment decisions for people with food insecurity and seek local resources to help people with diabetes and their family members obtain nutritious food more regularly (109).

Homelessness and housing insecurity often accompany other barriers that limit diabetes self-management. Food insecurity, lack of insurance, cognitive impairment, behavioral health deficiencies, and low literacy and numeracy skills are also factors (110). The prevalence of diabetes in the homeless population is estimated to be around 8% (111). Additionally, people with diabetes who are homeless need secure places to keep their diabetes supplies and refrigerator access to properly store their insulin and take it on a regular schedule. The risk for homelessness can be ascertained using a brief risk assessment tool developed and validated for use among veterans (112). Housing insecurity has also been shown to be directly associated with a person’s ability to maintain their diabetes self-management (113). Given the potential challenges, health care professionals who care for either homeless or housing-insecure individuals should be familiar with resources or have access to social workers who can facilitate stable housing for these individuals as a way to improve diabetes care (114).

Migrant and seasonal agricultural workers may have a higher risk of type 2 diabetes than the overall population. While migrant farmworker–specific data are lacking, most agricultural workers in the U.S. are Latino, a population with a high rate of type 2 diabetes. In addition, living in severe poverty brings with it food in-security, high chronic stress, and an increased risk of diabetes; there is also an association between the use of certain pesticides and the incidence of diabetes (115).

Data from the Department of Labor indicate that there are 2.5–3 million agricultural workers in the U.S. These agricultural workers travel throughout the country, serving as the backbone for a multibillion-dollar agricultural industry. According to 2021 health center data, 175 health centers across the U.S. reported that they provided health care services to 893,260 adult agricultural patients, and 91,124 had encounters for diabetes (10.2%) (116).

Migrant farmworkers encounter numerous and overlapping barriers to receiving care. Migration, which may occur as frequently as every few weeks for farmworkers, disrupts care. In addition, cultural and linguistic barriers, lack of transportation and money, lack of available work hours, unfamiliarity with new communities, lack of access to resources, and other barriers prevent migrant farmworkers from accessing health care. Without regular care, those with diabetes may suffer severe and often expensive complications that affect quality of life. Nontraditional care delivery models, including mobile integrated health and telehealth, can be leveraged to improve access to high quality care.

Health care professionals should be attuned to all patients’ working and living conditions. For example, if a migrant farmworker with diabetes presents for care, appropriate referrals should be initiated to social workers and community resources, as available, to assist with removing barriers to care.

Health care professionals who care for non–English speakers should develop or offer educational programs and materials in culturally adaptive languages specific to these individuals with the specific goals of preventing diabetes and building diabetes awareness in people who cannot easily read or write in English. The National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care (National CLAS Standards) provide guidance on how health care professionals can reduce language barriers by improving their cultural competency, addressing health literacy, and ensuring communication with language assistance (117). In addition, the National CLAS Standards website offers several resources and materials that can be used to improve the quality of care delivery to non–English-speaking individuals (117).

Health literacy is defined as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate decisions (77). Health literacy is strongly associated with patients engaging in complex disease management and self-care (118). Approximately 80 million adults in the U.S. are estimated to have limited or low health literacy (78). Clinicians and diabetes care and education specialists should ensure they provide easy-to-understand information and reduce unnecessary complexity when developing care plans with people with diabetes. Interventions addressing low health literacy in populations with diabetes seem effective in improving diabetes outcomes, including ones focusing primarily on patient education, self-care training, or disease management. Combining easily adapted materials with formal diabetes education demonstrates effectiveness on clinical and behavioral outcomes in populations with low literacy (119). However, evidence supporting these strategies is largely limited to observational studies. More research is needed to investigate the most effective strategies for enhancing both acquisition and retention of diabetes knowledge and examine different media and strategies for delivering interventions to people with diabetes (120).

Health numeracy is also essential in diabetes prevention and management. Health numeracy requires primary numeric skills, applied health numeracy, and interpretive health numeracy. An emotional component also affects a person’s ability to understand concepts of risk, probability, and communication of scientific evidence (121). People with prediabetes or diabetes often need to perform numeric tasks such as interpreting food labels and blood glucose levels to make treatment decisions such as medication dosing. Thus, both health literacy and numeracy are necessary for enabling effective communication between people with diabetes and health professionals, arriving at a treatment plan, and making diabetes self-management task decisions. If people with diabetes appear not to understand concepts associated with treatment decisions, both can be assessed using standardized screening measures (122). Adjunctive education and support may be indicated if limited health literacy and numeracy are barriers to optimal care decisions (31).

Social capital, which comprises community and personal network instrumental support, promotes better health, whereas lack of social support is associated with poorer health outcomes in individuals with diabetes (90). Of particular concern are the SDOH, including racism and discrimination, which are likely to be lifelong (123). These factors are rarely addressed in routine treatment or disease management but may be underlying reasons for lower engagement in self-care behaviors and medication use. Community resources are recognized by the CCM as a core component of chronic care management (10), with a particular need to incorporate relevant social support networks. There is currently a paucity of evidence regarding enhancing these resources for those most likely to benefit from such intervention strategies.

Health care community linkages are receiving increasing attention from the American Medical Association, the Agency for Healthcare Research and Quality, and others to promote the translation of clinical recommendations for nutrition and physical activity in real-world settings (124). Community health workers (CHWs) (125), community paramedics (126), peer supporters (127–129), and lay leaders (130) may assist in the delivery of DSMES services (92,131), particularly in underserved communities. The American Public Health Association defines a CHW as a “frontline public health worker who is a trusted member of and/or has an unusually close understanding of the community served” (132). CHWs can be part of a cost-effective, evidence-based strategy to improve the management of diabetes and cardiovascular risk factors in underserved communities and health care systems (133). The CHW scope of practice in areas such as outreach and communication, advocacy, social support, basic health education, referrals to community clinics, and other services has successfully provided social and primary preventive services to underserved populations in rural and hard-to-reach communities. Even though CHWs’ core competencies are not clinical in nature, in some circumstances, clinicians may delegate limited clinical tasks to CHWs. If such is the case, these tasks must always be performed under the direction and supervision of the delegating health professional and following state health care laws and statutes (134,135). Community paramedics are advanced paramedics with training in chronic disease monitoring and education, medication management, care coordination, and SDOH in addition to their emergency medical services expertise. While their scope of practice varies across states, community paramedics can engage and support people living with diabetes under the direction of a medical director by delivering diabetes education, assisting with medication management, performing health assessments and wound care, and connecting people with diabetes and care partners with clinical and community resources (126).